INTRODUCTION
The clustering of neurotransmitter receptors is a hallmark for postsynaptic differentiation. At the vertebrate neuromuscular junction (NMJ), the clustering of acetylcholine receptors (AChRs) is believed to be regulated by positive and negative factors, which determine strengthening of innervated AChR clusters and dispersion of aneural clusters, respectively (Lin et al., 2001; Lichtman, 1999, 2001) . The interplay between positive and negative signals results in the precise matching of motor nerve terminals to individual postsynaptic sites enriched with AChRs.
Genetic evidence suggests that postsynaptic AChR clustering is initiated by a nerve-independent mechanism and is prepatterned with the muscle at early developmental stages (Lin et al., 2001; Yang et al., 2001) . Afterward, the navigating nerve terminals release a glycoprotein agrin, which acts through its newly identified receptor LRP4 (Kim et al., 2008; Zhang et al., 2008) , leading to the activation of muscle specific kinase (MuSK) and the subsequent formation of new clusters or stabilization of the existing clusters (McMahan, 1990; Lichtman, 1999, 2001 ). Several molecules have been shown to be involved in agrin/MuSK signaling and AChR clustering, including AChR-associated protein rapsyn, MuSK binding proteins Dok7, Dishevelled1 (Dvl1), geranylgeranyltransferase I (GGT), Abl kinase, and Rho family of small GTPases (Finn et al., 2003; Gautam et al., 1995; Luo et al., 2002 Luo et al., , 2003 Okada et al., 2006; Weston et al., 2000; Wu et al., 2010) . Meanwhile, motor neurons release negative signals to disperse the AChR clusters that are not innervated by nerves. Recent evidence suggests that neurotransmitter ACh acts as a negative signal that disperses AChR clusters and agrin acts to stabilize AChR clusters through counteracting the dispersing activity of ACh (Kummer et al., 2006; Lin et al., 2005; Misgeld et al., 2005) . The mechanism of ACh action in dispersing AChR clusters is just beginning to be understood (Chen et al., 2007; Fu et al., 2005; Lin et al., 2005; Yang et al., 2011) . However, the intracellular interplay between positive and negative signaling remains elusive. Here, we provide evidence showing that caspase-3 acts as a mediator in inducing the dispersion of AChR clusters via the cleavage of MuSK signaling protein Dvl1.
Caspase-3 is one of the effector proteases that are usually known as mediators of cell death (Earnshaw et al., 1999; Troy and Salvesen, 2002; Yuan and Yankner, 2000) . Growing lines of evidence, however, suggest that caspases are more than just cell killers, rather they play critical roles in various, nonapoptotic aspects of normal cellular functions via specific and limited proteolysis (Fadeel et al., 2000; Los et al., 2001; McLaughlin, 2004) . In nerve system, apoptotic mechanisms have been considered to be involved in regulating the structural and functional plasticity of neuronal circuits under physiological conditions (Campbell and Holt, 2003; Gilman and Mattson, 2002; Gulyaeva et al., 2003; Huesmann and Clayton, 2006; Mattson and Duan, 1999; McLaughlin, 2004; Ohsawa et al., 2010) . For example, caspases have been shown to be involved in dendritic pruning (Kuo et al., 2006; Williams et al., 2006) , axon pruning (Nikolaev et al., 2009) , or growth cone dynamics (Campbell and Holt, 2003) , without causing full apoptotic cascades. Moreover, activation of caspase-3 has been shown to modulate neuronal excitability and plasticity (Chan and Mattson, 1999; Gulyaeva et al., 2003; Li et al., 2010; . Nevertheless, the role of caspase-3 during synapse development remains unknown.
Here, we have demonstrated an unexpected role of caspase-3 in the refinement of neuromuscular synapses, uncovering another nonapoptotic role of caspase-3 in synaptic pruning during early development.
RESULTS

Activation of Caspase-3 by Cholinergic Stimulation of Cultured Muscle Cells
Nerve-derived ACh has been shown to be responsible for the elimination of AChR clusters that are not stabilized by agrin (Lin et al., 2005; Misgeld et al., 2005) (Figure 1A ). Interestingly, we found that treatment with carbachol (CCh), a nonhydrolyzable cholinergic agonist at a concentration (0.1 mM) that is sufficient to induce the dispersion of AChR clusters in C2C12 myotubes (Chen et al., 2007; Lin et al., 2005) , caused an increase in the level of cleaved caspase-3, the active form of caspase-3, indicating that CCh may activate caspase-3 ( Figure 1B ). This effect peaked around 30 min after CCh treatment and declined thereafter ( Figure 1B) . Next, we determined caspase-3 activity by a more direct assay using Ac-DEVD-pNA as the substrate. As shown in Figure 1C , CCh stimulation caused a gradual increase in caspase-3 activity. Of note, the same (0.1 mM) or overdose (0.3 mM) CCh treatment failed to cause C2C12 muscle cell apoptosis and thus had no effect on cell health (Figures S1A and S1B available online), probably because of limited and localized activation of caspase-3. As a control, treatment with Staurosporine (1 mM), a natural product with apoptosis-inducing activity , caused marked cell apoptosis, as indicated by a marked increase in the percentage of condensed nuclei ( Figure S1A and S1B).
To further determine the specificity of the observed changes in caspase-3 activity, we did the analyses in caspase-3 mutant muscle cells. We found that the bands of active caspase-3 or activity of caspase-3 were not observed in muscle cells derived from caspase-3-deficient mice (caspase-3 À/À ) (Kuida et al., 1996) , even after treatment with Staurosporine, suggesting the specificity of the antibody and the Ac-DEVD-pNA probe ( Figures  S1C and S1D ). The effect of CCh on caspase-3 activity was abolished when muscle cells were pretreated with agrin, caspase-3 inhibitor Ac-DEVD-CMK (DEVD), or caspase-9 inhibitor Z-LEHD-FMK (LEHD), but not with caspase-8 inhibitor Z-IETD-FMK (IETD) ( Figure 1D ), suggesting complex signaling cascades in regulating caspase-3 activity. Indeed, caspase-3 activity, measured by staining with either active caspase-3 antibody (Figure 1E ) or a fluorescence substrate FITC-DEVD-FMK ( Figure 1F ), was spatially distributed in regions enriched with AChR clusters in myotubes treated with CCh (0.1 mM, 1 hr) but was not observed in muscle cells exposed to agrin (10 ng/ml) ( Figures  1E and 1F ). In contrast, treatment with Staurosporine (1 mM) caused an increase in caspase-3 activity throughout the whole cell in wild-type, but not in caspase-3 À/À muscle cells (Figures S1E and S1F) . These results may explain why CCh treatment failed to cause cell apoptosis. Next, we determined active caspase-3 signals at the stage when aneural clusters are refined in diaphragms of mice at embryonic day 16 (E16) and found that active caspase-3 was distributed in regions with aneural AChR clusters ( Figure 1G ). We also compared intensity of active caspase-3 that was associated with neural and aneural AChR clusters in motoneuron-muscle coculture system. Isolated motor neurons, which were positively stained with HB9 antibody (Figure S1G ), from rat spinal cord were transfected with mCherry-tagged-Channelrhodopsin-2 (ChR2), a light-gated cation channel used to control neuronal activity ( Figure S1H ) (Nagel et al., 2002 (Nagel et al., , 2003 , and cocultured with fully differentiated myotubes ( Figure 1H ). After 2 hr blue light-pulse treatment, we determined the intensity of active caspase-3 in muscle cells and found that regions with aneural AChR clusters exhibited higher caspase-3 activity, compared to background or regions with innervated clusters in wild-type ( Figures 1H  and 1J ), but not in caspase-3 À/À muscle cells ( Figure S1I ). In contrast, in cultures without light stimulation, the intensity of active caspase-3 in either neural or aneural cluster regions was similar with that of the background ( Figures 1H and 1J ). These results suggest that evoked neuronal activity of presynaptic nerves, via stimulating the release of neurotransmitter ACh, causes an elevation of nonsynaptic caspase-3 activity in muscle cells and that caspase-3 is locally inhibited by nerve-derived factors, such as agrin. In line with this hypothesis, the lightinduced increase in activated caspase-3 associated with aneural clusters was not observed in muscle cells cultured with ChR2 motor neurons with the downregulation of choline acetyltransferase (ChAT), the enzyme responsible for the synthesis of ACh (Santamaria et al., 2009) (Figures 1H-1J ). The spatial activity of caspase-3 associated with aneural AChR clusters may be due to the recruitment of caspase-3 or its regulatory machinery to postsynaptic structures.
Caspase-3 Activation Promotes the Dispersion of AChR Clusters
The activity of caspase-3 associated with aneural AChR clusters ( Figures 1G-1J ) and the activation of caspase-3 by cholinergic stimulation ( Figures 1B-1F ) raised the possibility for a role of caspase-3 in mediating the elimination of AChR clusters. To determine this possibility, C2C12 myotubes were first treated with agrin (10 ng/ml, 12 hr) to induce the formation of AChR clusters and then switched to agrin-free medium in the presence of CCh (0.1 mM) with or without DEVD (20 mM) for additional 2 hr ( Figure 2A ). We found that CCh treatment promoted elimination of AChR clusters, as reflected from reduced total length and number of clusters ( Figures 2B-2D ), in agreement with early reports that CCh destabilizes AChR clusters (Lin et al., 2005; Misgeld et al., 2005) . Interestingly, the dispersing effect of CCh was ameliorated in DEVD-treated cells (Figures 2A-2D ), suggesting that caspase-3 may mediate ''cholinergic'' agonist-induced elimination of AChR clusters. With the concern for the potential side effect of pharmacological treatment, we next determined the role of caspase-3 by analyzing muscle cells derived from caspase-3 mutant mice. Percentage of CCh-induced caspase-3 activity after various treatments is shown as mean ± SEM from three independent experiments. ***p < 0.001, **p < 0.01, *p < 0.05; ANOVA with Tukey's post hoc tests. The mean value of increased caspase-3 activity after CCh stimulation was taken as 100% (Ctrl).
(legend continued on next page)
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Caspase-3 in Synapse Elimination (Figures 2F and 2G) . However, this effect was markedly dampened in caspase-3 À/À muscle cells (Figures 2F and 2G) . These results support the notion that caspase-3 is involved in ''cholinergic'' stimulation-induced dispersal of AChR clusters.
To further determine the role of caspase-3 in dispersing AChR clusters in vivo, we analyzed neuromuscular phenotype of caspase-3 mutant mice (Kuida et al., 1996) . The caspase-3 À/À mice bred from heterozygotes (Casps3 +/À ) on the C57BL/6 mice background can survive at least 6 months. As shown in several previously studies, wild-type and mutant littermates did not differ grossly in the brain and spinal cord (Le et al., 2002; Oppenheim et al., 2001 2I ). This result supports again that caspase-3 is involved in the dispersion of aneural AChR clusters.
Dvl1 as the Substrate of Caspase-3
Next, we asked how caspase-3 activation executed a cluster dispersing effect. We searched for postsynaptic proteins that contain conserved caspase-3 cleavage site ''DXXD'' (Thornberry et al., 1997) and noted that Dvl1 and b-catenin, which bind to MuSK and rapsyn (Luo et al., 2002; Zhang et al., 2007a) , respectively, are potential caspase-3 targets. Interestingly, the cleavage site of Dvl1 resides in the DEP domain, which mediates interaction with MuSK and is essential for AChR cluster formation (Jing et al., 2009; Luo et al., 2002 ) ( Figure 3A ). To determine whether cholinergic stimulation induces the cleavage of Dvl1, we detected levels of cleaved fragment of Dvl1 using an antibody raised against C terminus of Dvl1 (Luo et al., 2002) . We found that CCh treatment caused a marked increase in the level of 32 kDa cleaved Dvl1 fragment ( Figure 3B , lanes 1-3; Figures 3C and S2B), with the band size equivalent to predicated cleavage product by caspase-3 ( Figure 3A ). This cleavage was prevented by pretreatment with agrin (10 ng/ml), DEVD (20 mM), or TAT-Dvl1 (40 mM), a cell-penetrating peptide composed of the TAT sequence derived from the transactivator of transcription of human immunodeficiency virus (Nagahara et al., 1998) and the caspase-3 cleavage site of Dvl1 (Figures 3B, lanes 4-6, and 3C), but not by same amount (40 mM) of the TAT peptide fused with scrambled sequence (TAT-Scr) ( Figure S2A , compare lanes 3 and 4). Other evidence supporting that the 32 kDa fragment was indeed derived from caspase-3 cleavage of Dvl1 came from observations that the cleaved fragment was markedly decreased in caspase-3 À/À muscle cells compared to that of wild-type muscle cells ( Figure S1C ) and that it was barely detectable in mutant muscle cells with Dvl1 downregulation (Figure S2B ). We observed no apparent cleavage of b-catenin in muscle cells with either CCh (0.1 mM, 1 hr) or Staurosporine (1 mM, 2 hr) treatments ( Figures S2C and S2D ). Thus, cholinergic activation induces the caspase-3-mediated truncation of Dvl1. The specificity of TAT-Dvl1 peptide in inhibiting Dvl1 cleavage was further determined by probing Akt, another substrate of caspase-3, which has been shown recently to be involved in caspase-3-mediated LTD induction (Li et al., 2010) . We treated C2C12 myotubes with 0.1 mM CCh or 1 mM Staurosporine and found that both treatments caused activation of caspase-3 and induced the cleavage of Akt ( Figures 3D and 3E) . Notably, the Akt cleavage was prevented by pretreatment with DEVD, but not by TAT-Dvl1 ( Figure 3D , compare lanes 3 and 4 and 6 and 7; Figure 3E ). The selective effect of TAT-Dvl1 may be determined by different spatial localization of substrates or enzymesubstrates affinities. The effectiveness of TAT-Dvl1 was further determined in a cell-free system with purified active caspase-3 added to muscle cell lysates, which contain endogenous Dvl1. As expected, incubation with caspase-3 caused a decrease in the level of full-length Dvl1 and an increase in the level of cleaved Dvl1 (Figures 3F, lanes 1-3, and 4I, lanes 1 and 2; Figure S2E , compare lanes 1 and 3), indicating the cleavage of Dvl1 by caspase-3. Remarkably, this cleavage was inhibited in the presence of TAT-Dvl1 peptide ( Figure 3F , compare lanes 3 and 4; Figure S2E , compare lanes 3 and 4). Notably, in this cell-free system, caspase-3 treatment of lysates from Dvl1 knockdown cells did not cause the elevation of the 32 kDa band ( Figure S2E , compare lanes 2 and 3), indicating again the specificity of Dvl1 cleavage by caspase-3.
Blocking Dvl1 Cleavage Prevents the Dispersion of AChR Clusters
Next, we used the TAT-Dvl1 peptide to block the caspase-3 cleavage of Dvl1 and determined its effect on the stability of AChR clusters. As shown in Figure 4A , the role of CCh (0.1 mM, 1 hr) in inducing cluster dispersion was markedly prevented in myotubes pretreated with TAT-Dvl1 (40 mM, 0.5 hr), but not by TAT-Scr. The antidispersing effect was reflected in rescued number or total length of AChR clusters (Figures 4B (E) C2C12 myotubes were treated with CCh (0.1 mM), without or with agrin (10 ng/ml) for 1 hr, followed by staining with antibody against active form of caspase-3 and R-BTX for AChR clusters. Scale bar, 5 mm. (F) C2C12 myotubes were treated with 0.1 mM CCh, either alone or together with agrin (10 ng/ml), for 1 hr, and activity of caspase-3 was detected by FITC-DEVD-FMK. AChR clusters were marked by R-BTX. Scale bar, 5 mm. (G) E16 mice diaphragms were whole-mount stained with antibodies against active caspase-3 and Smi-312, and R-BTX for AChR clusters. The arrow indicates signals of active caspase-3 associated with an aneural AChR cluster. Scale bar, 10 mm. (H) Motor neurons transfected with ChR2-mCherry, without or with siRNA against ChAT (siChAT) or scrambled sequence (siCtrl), were cocultured with C2C12 myotubes. After blue light stimulation, cultures were stained with R-BTX and active caspase-3 antibody. Innervated and aneural AChR clusters, which were at least 5 mm away from motor axons, are indicated by yellow and white arrows, respectively. Scale bar, 10 mm. (I) Efficiency of siChAT in cultured motoneurons. ***p < 0.001, Student's t test (siCtrl, n = 12; siChAT, n = 10 cells). Scale bar, 20 mm. (J) Spatial caspase-3 activity in nerve-muscle coculture system. Data are presented as mean ± SEM for relative levels of active caspase-3 in AChR cluster regions against background regions from three experiments (numbers of muscle cells: 22 for control without light, 22 for control with light, 27 for siCtrl with light, and 34 for siChAT with light). ***p < 0.001, **p < 0.01; N.S., not significant; two-way ANOVA with Tukey's post hoc tests or Student's t test. See also Figure S1 . (legend continued on next page) and 4C). Thus, caspase-3 mediates the ACh-dependent dispersion of AChR clusters, probably through the cleavage of Dvl1. Given the local activity of caspase-3 associated with aneural AChR clusters ( Figures 1E-1J) , we determined the effect of TAT-Dvl1 on the stability of AChR clusters in motoneuronmuscle coculture system, where neuronal activity could be manipulated by light-gated ChR2. Notably, blue light-pulse stimulation resulted in a marked decrease in the number or length of aneural AChR clusters (Figures 4D-4F) . Interestingly, this lightinduced cluster dispersion was largely prevented by pretreatment with TAT-Dvl1, but not with TAT-Scr ( Figures 4D-4F ). These results can be interpreted as that activity-triggered synaptic ACh release causes the onset of electrical activity in postsynaptic muscle cells, leading to caspase-3 activation, cleavage of Dvl1, and finally the dispersion of AChR clusters.
To further confirm the role of Dvl1 as the functional substrate of caspase-3 in dispersing AChR clusters, we generated lentivirus constructs, which drive expression of wild-type or a mutated form of Dvl1 (Dvl1res) and thus should be resistant to caspase-3 cleavage; the caspase-3 cleavage site ''DVVD'' was changed to ''AVVA'' ( Figure 4G ). The Dvl1 proteins expressed well in infected myotubes, with wild-type and mutant at comparable levels (Figure 4H) . The Dvl1res was resistant to caspase-3 cleavage in a cell-free system ( Figure 4I, lanes 3 and 4) , whereas the wildtype Dvl1 (Dvl1wt) was very sensitive to caspase-3 ( Figure 4I , lanes 1 and 2). We found that the expression of Dvl1res had no effect on the formation of AChR clusters, whereas it stabilized AChR clusters under the condition with CCh treatments, with an effect more significant than that caused by Dvl1wt ( Figures  4J-4L ). These results support the notion that Dvl1 cleavage by caspase-3 mediates ACh-induced dispersion of AChR clusters.
Next, we determined effects of Dvl1 overexpression in vivo by injecting lentivirus encoding mutant or wild-type Dvl1 into the chest of embryonic mice at E14. The empty lentivirus construct encoding GFP was coinjected to mark infected muscle cells in diaphragms ( Figure 4M ). Four days after virus injection, E18 mice diaphragms were stained for patterns of AChR clusters and axons, which were labeled by Smi-312 antibody ( Figure 4M ). Given the chimeric expression of target proteins in muscle cells, we only analyzed GFP-positive myotubes. We found that Dvl1res-expressing muscles exhibited a marked increase in the percentage of aneural AChR clusters, compared to control or Dvl1wt groups ( Figure 4N ). In addition, the endplate width was bigger in Dvl1res-infected animals than that of other two groups ( Figure 4O ). These results have provided strong evidence supporting the conclusion that Dvl1 acts as a key substrate of caspase-3 in AChR cluster disassembly following innervations in vivo.
Inhibition or Genetic Ablation of Caspase-3 Rescues AChR Clusters in Agrin Mutant Mice
It is believed that agrin stabilizes innervated AChR clusters by counteracting the dispersing role of ACh (Lin et al., 2005; Misgeld et al., 2005) . To circumvent the interference of agrin action on caspase-3, we chose to inhibit or delete caspase-3 in agrin mutant mice and then determined the stability of AChR clusters. First, we injected DEVD into the chest of E14 mice to suppress caspase-3 activity in the diaphragms. E17 diaphragm muscles of agrin mutant (agrin À/À ) mice (Burgess et al., 1999) were stained for presynaptic motor nerve terminals and postsynaptic AChR clusters. By E17, most prepatterned aneural AChR clusters should have been eliminated (Sanes and Lichtman, 2001 ). As expected, only a few AChR clusters were present in the muscle of agrin À/À mice injected with vehicle DMSO ( Figure 5A , top row). However, numerous AChR clusters were observed when agrin À/À mice were treated with DEVD ( Figure 5A , bottom row).
Interestingly, most of these AChR clusters were not apposed by nerve terminals ( Figure 5A ). Quantitatively, both average area of individual clusters and the number of clusters were significantly increased in DEVD-treated agrin ; Casps3 +/À mice at E17 ( Figures 5D and 5E ) or E15 (Figures S3A and S3B ). The size of AChR clusters were also increased in agrin À/À ; Casps3 À/À mice at E17 ( Figure 5F ), but not at E15 ( Figure S3C ). Similar to that caused by DEVD treatment, most rescued clusters were not apposed to synaptophysin-labeled nerve terminals ( Figure 5D , see magnified areas; Figure S3A ) and distribution of axons was similar between two groups ( Figures S3D and S3E ). Of note, these clusters were colocalized with some synaptic proteins, such as laminin b2 or rapsyn ( Figure S3F ). These results indicate that caspase-3 inhibition increased stability of aneural AChR clusters in the skeletal muscle but had no effect on gross axon distribution. Besides defects in postsynaptic differentiation, agrin knockouts also exhibit poor differentiation of presynaptic structures, including lack of synaptic vesicles in motor axons, which are loosely associated with Schwann cells (Gautam et al., 1996) . To gain deep insights into the ultrastructure of NMJs in caspase-3 and agrin double knockout mice, we did electron microscopy (EM) analysis for wild-type and mutant mice. As shown in Figure 5G (top row), muscles of wild-type mice at E17 were normally innervated by axons (Ax) that contained accumulations of synaptic vesicles, and occasionally active zones, and were usually wrapped by electron dense Schwann cell (Sc) processes. It is known that at this stage the postsynaptic structures are premature and junctional folds are difficult to discern (Desaki and Uehara, 1987; Sanes and Lichtman, 1999) . In agreement with the previous report (Gautam et al., 1996) , agrin À/À mice showed severe defects in synaptic differentiation, including the lack of vesicles and the loose association of Schwann cells with axon terminals ( Figure 5G , middle row).
Interestingly, the axon structures were better preserved in agrin
; caspase-3 À/À mice, as evidenced by the appearance of numerous vesicles in axon terminals, which abutted myotube membranes ( Figure 5G , bottom row). Sometimes, multiple axon (D) C2C12 myotubes were pretreated with DEVD (20 mM) or TAT-Dvl1 peptide (40 mM) for 0.5 hr, followed by treatments with 0.1 mM CCh for 1 hr or 1 mM Stauosporine for 3 hr. Cell lysates were subjected to IB with anti-AKT antibody, which recognizes total and cleaved AKT, or antibody recognizing active caspase-3. (E) Quantification for the cleavage of AKT. The ratio for the intensity of cleaved Akt and total Akt was analyzed in each set of experiment with values from Staurosporine or CCh alone normalized as 1.0. Data are shown as mean ± SEM from three experiments. *p < 0.05; ***p < 0.001; ANOVA with Tukey's post hoc tests. (F) C2C12 muscle cell lysates (100 mg proteins in 20 ml NP40 buffer with 10% glycerol) were incubated at 37 C with indicated amount of caspase-3 for 16 hr, without or with TAT-Dvl1 peptide (4 mM), and then subjected to IB with anti-Dvl1 antibody. Shown is a representative result with numbers underneath blots indicating relative intensity of full-length (top row) and cleaved Dvl1 (bottom row) with the value without caspase-3 normalized as 1. See also Figure S2 .
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Caspase-3 in Synapse Elimination terminals were observed in close apposition with muscle membranes ( Figure 5G , bottom row, right lane). Notably, Schwann cells were still loosely associated with axons or even absent in double knockouts ( Figure 5G , bottom row). Given the similar patterns of axon distribution ( Figures S3D and S3E) , the ultrastructural changes of the NMJs in caspase-3 and agrin double knockout mice compared to agrin knockout mice were most likely caused by the rescue of postsynaptic structures, which may provide retrograde signaling for presynaptic differentiation.
Caspase-3 Cleavage of Dvl1 Affects Postsynaptic Signaling How does the prevention of Dvl1 cleavage protect AChR clusters from being dispersed? Previously, we have shown that Dvl1 interaction with MuSK is important for agrin-induced AChR clustering (Luo et al., 2002) . Given that the cleavage site in Dvl1 resides within the DEP domain that mediates the interaction with MuSK, we determined whether CCh stimulation affects the interaction between MuSK and Dvl1. In agreement with our previous observation (Luo et al., 2002) , we found that immunoprecipitation (IP) of Dvl1 caused coIP of MuSK in wild-type muscle cells ( Figure 6A, left) . Notably, treatment with CCh (0.1 mM, 2 hr) caused a decrease in the amount of MuSK associated with Dvl1, suggesting that ''cholinergic'' stimulation affects agrin/ MuSK signaling for AChR clustering. Interestingly, the disassembly effect of CCh on MuSK-Dvl1 complex was not observed in caspase-3 À/À muscle cells ( Figure 6A , right), indicating that caspase-3 is involved in disrupting the agrin/MuSK signaling. The tumor suppressor Adenomatous Polyposis Coli (APC) binds directly to Dvl (Matsumoto et al., 2010) and has been shown to be critical for the formation and stabilization of AChR clusters . We found that agrin treatment caused clustering of APC, which was colocalized with AChR clusters ( Figure 6B ). Interestingly, short-term treatment with CCh (0.1 mM, 0.5 hr) induced dispersion of APC clusters ( Figures  6B and 6C ), without apparent effect on AChR clusters (Figure 6B ). This result suggests that CCh-induced disassembly of APC clusters happens early than declustering of AChR clusters. Interestingly, pretreatment with TAT-Dvl1 (40 mM, 0.5 hr), but not with TAT-Scr, markedly prevented the dispersal of APC clusters ( Figures 6B and 6C ). In addition, overexpression of Dvl1res stabilized APC clusters with a more marked effect than that caused by Dvl1wt (Figures 6B and 6C) . Thus, the cleavage of Dvl1 at the DEP domain by caspase-3 affects the stability of AChR clusters, probably through disassembly of MuSK signaling and/or destabilization of APC clusters.
Agrin Inhibits Caspase-3 and Stabilizes AChR Clusters through Heat Shock Protein 90
How does agrin regulate caspase-3 activity? It has been shown that heat shock protein 90b (HSP90b) regulates AChR cluster formation and maintenance by stabilizing rapsyn . Indeed, several heat shock proteins, including HSP70 and 90, are known to execute an antiapoptotic role by inhibiting caspase-3, directly or indirectly (Garrido et al., 2001) . To determine the relationship between HSP90 and caspase-3 activity, we treated muscle cells with CCh, in the absence or presence of agrin, without or with 17-(allylamino)-17-demethoxygeldanamycin (17-AAG), an inhibitor of HSP90 (Stebbins et al., 1997) . We found that the inhibitory effect of agrin on CCh-induced caspase-3 activity was completely prevented by 17-AAG (Figures 7A and 7B) . Furthermore, the protective role of agrin in CCh-induced AChR cluster dispersion was prevented by 17-AAG treatment (Figures 7C-7E) . The same 17-AAG treatment, either alone or in the presence of CCh, had no effect on cell health, as indicated by similar low percentage of condensed nuclei compared to vehicle control group (Figures S4A and  S4B) . To exclude the possible side effect of 17-AAG, we downregulated the expression of HSP90b in muscle cells using small interfering RNAs (siRNAs) ( Figure 7F ) and found that agrin was unable to stabilize AChR clusters in HSP90b knockdown cells ( Figures 7G-7I ), although downregulation of HSP90b, without or with CCh treatment, had no effect on cell health ( Figures  S4A and S4B) . Thus, HSP90b at the NMJ may help to inhibit caspase-3 locally, in addition to its role in protecting rapsyn, leading to the stabilization of innervated AChR clusters.
Because HSP90 is reported to bind and suppress apoptotic protease activating factor 1 (Apaf-1), an adaptor protein essential for caspase-3 activation in the mitochondria pathway (Pandey et al., 2000; Yuan and Yankner, 2000) , we decided to test the role of Apaf-1 in regulating the stability of AChR clusters. We found that in muscle cells with the downregulation of Apaf-1 (Figure S4C ), the CCh-induced dispersion of AChR clusters was partially prevented (Figures S4D-S4F ), suggesting that (D) ChR2-expressing motor neurons were cocultured with C2C12 myotubes, followed by no light or pulse blue-light stimulation for 2 hr, without or with TAT-Dvl1 or TAT-Scr peptides (40 mM). AChR clusters were marked by R-BTX. Scale bar, 10 mm. (E and F) Quantification for the number (E) or total length (F) of aneural AChR clusters in the innervated myotubes. Data are shown as mean ± SEM from three experiments. N.S., not significant; *p < 0.05, **p < 0.01, ***p < 0.001; ANOVA with Tukey's post hoc tests. The numbers of myotubes from three experiments are 69 for Ctrl no light, 77 for Ctrl with light, 51 for TAT-Scr with light, and 85 for TAT-Dvl1 with light. (G) Dvl1res, the mutated form of Dvl1 resistant to caspase-3 cleavage, was subcloned into lentivirus vector pLVU-tTR-KRAB. (H) Expression of Dvl1 in lentivirus-infected C2C12 myotubes. Note the comparable level of Dvl1wt and Dvl1res. (I) Lysates of C2C12 myotubes without or with lenti-Dvl1res infection were incubated with caspase-3 (0.5 mg) for 16 hr, followed by IB with Dvl1 antibody to determine the cleavage of Dvl1. (J) C2C12 myotubes infected with control (Ctrl) or lenti-Dvl1 were treated with agrin (10 ng/ml, 12 hr) to induce the formation of AChR clusters and then switched to agrin-free medium without or with CCh (0.1 mM) and incubated for additional 1 hr. AChR clusters were marked by R-BTX. Scale bar, 50 mm. (K and L) Quantification for the number (K) and total length (L) of AChR clusters under indicated conditions. Data are shown as mean ± SEM from four experiments. **p < 0.01, ***p < 0.001; ANOVA with Tukey's post hoc tests. At least 100 muscle cells were analyzed in each experimental condition. (M) Chests of E14 mice were injected with lentivirus expressing GFP, either alone or together with that expressing Dvl1wt or Dvl1res. Diaphragm muscles were dissected out at E18 and whole-mount stained with antibody against Smi-312, GFP, and R-BTX. GFP signal was used to mark infected muscle cells. Apaf-1 is involved in elimination of AChR clusters. Interestingly, it has been shown that local inhibition of caspase activity by X-linked inhibitor of apoptosis protein (XIAP) regulates dendrite pruning (Kuo et al., 2006) and synaptic function during learning (Huesmann and Clayton, 2006) . However, downregulation of XIAP had no effect on AChR cluster formation or stabilization (Figures S4G-S4J) . Thus, the modulatory mechanisms may be different in various cellular contexts.
DISCUSSION
Here, we have demonstrated a role of caspase-3 in the elimination of postsynaptic structures during neuromuscular synapse refinement. We propose that ACh-activation of caspase-3 is responsible for the elimination of aneural AChR clusters through the cleavage of MuSK signaling protein Dvl1. On the other hand, agrin inhibits ACh-induced activation of caspase-3 to stabilize innervated AChR clusters, most likely through HSP90b (Figure 7J) . Given that caspase-3 ablation only partially rescued NMJ defects in agrin mutant mice, it remains possible that there are other effectors that may be involved in sculpturing postsynaptic structures. Many caspase substrate proteins, including structure proteins, signal proteins, and some receptors, such as AMPA receptor subunit GluR1 are localized in pre-or postsynaptic compartments of neurons (Mattson and Duan, 1999) . Strictly controlled activation of caspases may result in local functional and morphological alterations without causing cell death. Here, we found that Dvl1, a Wnt signaling protein that has been shown to be involved in the formation of AChR, clusters in cultured muscle cells (Luo et al., 2002) and in the organization of synaptic prepattern during zebrafish neuromuscular development (Jing et al., 2009) , as the substrate of caspase-3. Interestingly, the caspase-3 cleavage site of Dvl1 resides in the DEP domain, which mediates the interaction between Dvl1 and MuSK (Luo et al., 2002) or APC (Matsumoto et al., 2010) . Indeed, the DEP domain of Dvl is important for AChR cluster formation in cultured muscle cells (Luo et al., 2002) or prepatterning of zebrafish neuromuscular synapses (Jing et al., 2009) . Of note, both Dvl and APC are Wnt signaling proteins, which play an important role in NMJ development (Wu et al., 2010) . Interestingly, Dvl has been shown to be involved in the stabilization of microtubules through the direct interaction with APC (Matsumoto et al., 2010) or inhibition of serine/threonine kinases, including glycogen synthase kinase 3 beta (GSK-3b) (Ciani et al., 2004) or microtubule affinity regulating kinase 2 (MARK2) (Zhang et al., 2007b) . APC itself is associated with microtubule plus end (Mimori-Kiyosue and Tsukita, 2001; Zumbrunn et al., 2001) , and interestingly, a recent report shows that capture of microtubules at the subsynaptic muscle membrane regulates AChR insertion into the postsynaptic membrane (Schmidt et al., 2012) . The disassembly of APC clusters by CCh suggests involvement of microtubules in the stabilization of AChR clusters. The caspase-3 cleavage of Dvl1 may result in changes in the postsynaptic microtubule structures, leading to destabilization of AChR clusters. Of note, genetic ablation of Dvl1 only affects AChR cluster distribution (Henriquez et al., 2008) . The subtle defect observed in Dvl1 À/À mice might be due to functional compensation by Dvl2 or Dvl3 (Henriquez et al., 2008) . Developmental Cell
Caspase-3 in Synapse Elimination
Synaptic elimination is a critical step in the establishment of proper neuronal connections. The role of caspase-3 in eliminating postsynaptic structures during neuromuscular synaptic refinement will provide further insights into mechanisms underlying central nervous system circuit formation.
EXPERIMENTAL PROCEDURES
Reagents, Constructs, and Mice All reagents, including antibodies, siRNAs, and constructs, and mice used in this study are introduced in the Supplemental Experimental Procedures. The use of animals is in compliance with the guidelines of the Institutional Animal Care and Use Committee.
Muscle Cell Culture and Treatments C2C12 muscle cells were cultured as described previously (Luo et al., 2002) . After genotyping, primary muscle cultures were prepared from limb muscles of neonatal mice and induced to become fully differentiated myotubes, as described previously (O'Malley et al., 1997) . C2C12 or primary myotubes were treated with indicated reagents, followed by staining with R-BTX for AChR clusters.
Coculture and Optogenetic Manipulation
Motor neurons were isolated from E14 Sprague-Dawley rats in accordance with the protocol introduced previously (Leach et al., 2011) with several modifications. Briefly, Spinal motor neurons were purified from the ventral spinal cords and dissociated with 0.125% trypsin. After transfection with ChR2-mCherry, without or with siChAT or siCtrl, by electroporation using the Amaxa Nucleofector, neurons were plated on differentiated C2C12 cells and maintained in Dulbecco's modified Eagle's medium supplemented with 3% horse serum. ChR2-mCherry-expressing motor neurons were stimulated under pulsed blue light (2 Hz, 10 ms per pulse, 10 pulses per train with 60 s interval) for 2 hr. Drugs were added into the medium 30 min before stimulation.
Light Activation and Electrophysiology
A whole-cell recording (in current clamp) of cultured motor neurons expressing ChR2 was made with glass micropipettes and an Axopatch 700A amplifier (Molecular Devices), with a shutter controlling the duration of blue-light stimuli. See the Supplemental Experimental Procedures for details.
Caspase-3 Activity Assay After various treatments, total and spatial activity of caspase-3 in cultured muscle cells was measured with Ac-DEVD-pNA (Beyotime) and FITC-DEVD-FMK (Calbiochem) as the substrates, respectively. See the Supplemental Experimental Procedures for details.
Virus or DEVD Injection into Embryonic Mice Chests
Pregnant mice on embryonic day 14 (E14) were anesthetized with sodium pentobarbital and subjected to abdominal incision to expose the uterus. Fetal mice chests were injected with drugs (15 mg DEVD or vehicle) or viruses (1.5 3 10 6 transducing units of lenti-Dvl1 plus 2 3 10 5 transducing units of lenti-GFP or lenti-GFP alone) mixed with 3-4 ml 0.05% Fast Green. Three or four days postinjection, diaphragms of E17 (for DEVD) or E18 (for viruses) mice were examined by immunohistochemistry.
Immunohistochemistry and Image Analysis
After various treatments, C2C12 myotubes were stained with R-BTX to label AChRs (Luo et al., 2003) . Images were collected with a Zeiss confocal microscope using a 403 objective. The total length of all AChR clusters or number of clusters bigger than 5 mm in 100 mm myotube were quantitatively analyzed. For diaphragm samples, the staining procedure was followed as reported in the previous study (Luo et al., 2003) . Synaptic nerve terminals were marked by staining with anti-synaptophysin antibody. AChR clusters labeled by R-BTX at the most ventral left side of the diaphragm that has little anatomical variation across mice were quantitatively analyzed. Numbers of AChR clusters were analyzed from images taken with a 203 objective, whereas AChR cluster area was determined from images with a 633 or 603 objective. Area and intensity of fluorescence signals were measured by Image-Pro Plus with the same fluorescence threshold. We used ImageJ (NeuronJ) software to trace all the AChR clusters, and clusters smaller than 5 mm were deleted from the results exported by ImageJ (NeuronJ). All the images were quantified by researchers who were blinded to experimental conditions.
Electron Microscopy Analysis
Diaphragms from E17 wild-type or mutant mice were fixed in 2.5% glutaraldehyde overnight and then fixed in 1% OsO 4 , followed by uranyl acetate staining and dehydration. Samples embedded in resin were sectioned with consecutive slices every 5 mm apart, and ultrathin sections were stained with lead citrate. Image analysis and acquisition were performed using transmission electron microscopy (TEM).
Quantitative Analysis
After analysis for the normal distribution and homogeneity of variance among values of the same set, pooled data were subject to statistical analysis using ANOVA supplemented with Tukey's post hoc tests or t tests. All the data were shown as mean ± SEM from at least three experiments (p < 0.05 is considered as significant difference). (C) C2C12 myotubes were treated with agrin (10 ng/ml) for 12 hr and then switched to agrin-free medium, followed by the treatment with CCh (0.1 mM, 2 hr), without or with pretreatment with agrin (10 ng/ml, 0.5 hr), or agrin plus 17-AAG (5 mM, 0.5 hr). AChR clusters were marked by R-BTX. Scale bar, 50 mm.
SUPPLEMENTAL INFORMATION
(D and E) Quantification for the number (D) and total length (E) of AChR clusters. Data are shown as mean ± SEM from three experiments. ***p < 0.001; ANOVA with Tukey's post hoc tests. The numbers of myotubes from three experiments are 142 for Ctrl, 175 for CCh, 122 for CCh+Agrin, and 175 for CCh+Agrin+17-AAG. (F) C2C12 myotubes were transfected without or with siHSP90b or siScr. After 72 hr, cell lysates were collected and subjected to IB with indicated antibodies. (G) C2C12 cells were transfected with or without siHSP90b or siScr, with cotransfected YFP to mark cell morphology. Fully differentiated myotubes were treated with agrin (10 ng/ml) for 12 hr and then switched to agrin-free medium, followed by treatment with CCh (0.1 mM, 2 hr), without or with pretreatment with agrin (10 ng/ml, 0.5 hr). See also Figure S4 .
